威尼托克拉克斯:在治疗年轻的AML患者方面改变了游戏规则?
Matteo Molica1, Salvatore Perrone2, Vincenzo Federico3
1Department of Hematology-Oncology, Azienda Universitaria Ospedaliera Renato Dulbecco, 88100 Catanzaro, Italy.
威尼托克拉克斯 (VEN) 与密集化疗相结合,改善了年轻急性髓性白血病 (AML) 患者的结局,增加了缓解率和无事件生存率. 这种方法增强了向干细胞移植的过渡,为AML治疗提供了新的标准.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 威尼托克拉克斯 (VEN) 加上阿扎西提丁 (AZA) 是老年人/不适合急性髓性白血病 (AML) 患者的标准.
- 在接受密集化疗的年轻AML患者中,复发仍然是主要的挑战.
- 目前正在探索针对性药物,以改善AML的治疗结果.
研究的目的:
- 在年轻的AML患者中审查VEN与密集化疗相结合的疗效.
- 评估VEN对可测量的残留疾病 (MRD) 消极性和无事件生存率的影响.
- 评估VEN在促进异性干细胞移植方面的作用.
主要方法:
- 审查当前的临床研究和试验.
- 对响应率,MRD消极性和生存率的数据分析.
- 专注于前线方案,将VEN与密集化疗相结合.
主要成果:
- 与密集化疗相结合的VEN在较年轻的AML中显示出深度MRD阴性缓解.
- 这种组合疗法可以延长无事件生存期.
- 它增强了全源干细胞移植在第一次完全缓解的可行性.
结论:
- 将VEN添加到密集化疗中,为年轻的AML患者提供了显著的优势.
- 这种方法为未来的临床试验设计设定了基准.
- 基于VEN的方案在AML的各种风险子类别中显示出希望.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
相关概念视频
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
